首页> 美国卫生研究院文献>Cytotechnology >Use of exogenous hTERT to immortalize primary human cells
【2h】

Use of exogenous hTERT to immortalize primary human cells

机译:使用外源性hTERT永生人类原代细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A major obstacle to the immortalization of primary human cells and the establishment of human cell lines is telomere-controlled senescence. Telomere-controlled senescence is caused by the shortening of telomeres that occurs each time somatic human cells divide. The enzyme telomerase can prevent the erosion of telomeres and block the onset of telomere-controlled senescence, but its expression is restricted to the early stages of embryonic development, and in the adult, to rare cells of the blood, skin and digestive track. However, we and others have shown that the transfer of an exogenous hTERT cDNA, encoding the catalytic subunit of human telomerase, can be used to prevent telomere shortening, overcome telomere-controlled senescence, and immortalize primary human cells. Most importantly, hTERT alone can immortalize cells without causing cancer-associated changes or altering phenotypic properties. Primary human cells that have so far been established by the forced expression of hTERT alone include fibroblasts, retinal pigmented epithelial cells, endothelial cells, oesophageal squamous cells, mammary epithelial cells, keratinocytes, osteoblasts, and Nestin-positive cells of the pancreas. In this article, we discuss the use of hTERT to immortalize of human cells, the properties of hTERT-immortalized cells, and their applications to cancer research and tissue engineering.
机译:初级人类细胞永生化和人类细胞系建立的主要障碍是端粒控制的衰老。端粒控制的衰老是由每次人体细胞分裂时发生的端粒缩短引起的。端粒酶可以防止端粒的侵蚀并阻止端粒控制的衰老的发生,但其表达仅限于胚胎发育的早期阶段,而在成年期则限于血液,皮肤和消化道的稀有细胞。但是,我们和其他人已经表明,编码人端粒酶催化亚基的外源性hTERT cDNA的转移可用于防止端粒缩短,克服端粒控制的衰老并永生人类原代细胞。最重要的是,仅hTERT就能使细胞永生,而不会引起癌症相关的变化或改变表型特性。迄今为止,仅通过hTERT的强制表达已建立的原代人类细胞包括成纤维细胞,视网膜色素上皮细胞,内皮细胞,食道鳞状细胞,乳腺上皮细胞,角质形成细胞,成骨细胞和胰腺Nestin阳性细胞。在本文中,我们讨论了使用hTERT永生化人类细胞,hTERT永生化细胞的特性及其在癌症研究和组织工程中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号